2021 WSES_AAST指南:炎症性肠病的急诊管理

2021-05-11 世界急诊外科学会 World J Emerg Surg.2021 May 11;16(1):23.

2021年5月,世界急诊外科学会(WSES)联合美国创伤外科协会(AAST)共同发布了炎症性肠病的急诊管理。尽管当前炎症性肠病的治疗方法有很多,但在紧急情况下仍需要手术治疗。本文主要针对紧急情况下炎症

中文标题:

2021 WSES_AAST指南:炎症性肠病的急诊管理

英文标题:

WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting

发布机构:

世界急诊外科学会

发布日期:

2021-05-11

简要介绍:

2021年5月,世界急诊外科学会(WSES)联合美国创伤外科协会(AAST)共同发布了炎症性肠病的急诊管理。尽管当前炎症性肠病的治疗方法有很多,但在紧急情况下仍需要手术治疗。本文主要针对紧急情况下炎症性肠病管理的相关问题提供指导意见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 WSES_AAST指南:炎症性肠病的急诊管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0d10b1c00210a885, title=2021 WSES_AAST指南:炎症性肠病的急诊管理, enTitle=WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting, guiderFrom=World J Emerg Surg.2021 May 11;16(1):23., authorId=0, author=, summary=2021年5月,世界急诊外科学会(WSES)联合美国创伤外科协会(AAST)共同发布了炎症性肠病的急诊管理。尽管当前炎症性肠病的治疗方法有很多,但在紧急情况下仍需要手术治疗。本文主要针对紧急情况下炎症, cover=https://img.medsci.cn/2021522/1621698243907_2020535.jpg, journalId=0, articlesId=null, associationId=1090, associationName=世界急诊外科学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue May 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月,世界急诊外科学会(WSES)联合美国创伤外科协会(AAST)共同发布了炎症性肠病的急诊管理。尽管当前炎症性肠病的治疗方法有很多,但在紧急情况下仍需要手术治疗。本文主要针对紧急情况下炎症性肠病管理的相关问题提供指导意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1125, tagName=炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1125, guiderKeyword=炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4097, appHits=158, showAppHits=0, pcHits=387, showPcHits=3939, likes=1, shares=21, comments=17, approvalStatus=1, publishedTime=Sat May 22 23:50:30 CST 2021, publishedTimeString=2021-05-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 22 23:44:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 05:43:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 WSES_AAST指南:炎症性肠病的急诊管理.pdf)])
2021 WSES_AAST指南:炎症性肠病的急诊管理.pdf
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1007569, encodeId=7267100e56952, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/af48f958601f48bd84e482cc4cb7adca/cbd79671c0e048498641df128b52a444.jpg, createdBy=5f561961370, createdName=刘奕奕), createdTime=Fri Aug 13 11:50:33 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006833, encodeId=6dad100683349, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbe82292593, createdName=121ec61em85暂无昵称, createdTime=Wed Aug 11 07:28:45 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976151, encodeId=58e49e61514c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Wed Jun 23 10:58:31 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973812, encodeId=c10a9e381278, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b675520743, createdName=ms7000002130458668, createdTime=Tue Jun 15 18:17:41 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973186, encodeId=214a9e3186e3, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6875519986, createdName=ms2000000998113974, createdTime=Sun Jun 13 00:20:21 CST 2021, time=2021-06-13, status=1, ipAttribution=)]
    2021-08-13 刘奕奕)

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1007569, encodeId=7267100e56952, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/af48f958601f48bd84e482cc4cb7adca/cbd79671c0e048498641df128b52a444.jpg, createdBy=5f561961370, createdName=刘奕奕), createdTime=Fri Aug 13 11:50:33 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006833, encodeId=6dad100683349, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbe82292593, createdName=121ec61em85暂无昵称, createdTime=Wed Aug 11 07:28:45 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976151, encodeId=58e49e61514c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Wed Jun 23 10:58:31 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973812, encodeId=c10a9e381278, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b675520743, createdName=ms7000002130458668, createdTime=Tue Jun 15 18:17:41 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973186, encodeId=214a9e3186e3, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6875519986, createdName=ms2000000998113974, createdTime=Sun Jun 13 00:20:21 CST 2021, time=2021-06-13, status=1, ipAttribution=)]
    2021-08-11 121ec61em85暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1007569, encodeId=7267100e56952, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/af48f958601f48bd84e482cc4cb7adca/cbd79671c0e048498641df128b52a444.jpg, createdBy=5f561961370, createdName=刘奕奕), createdTime=Fri Aug 13 11:50:33 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006833, encodeId=6dad100683349, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbe82292593, createdName=121ec61em85暂无昵称, createdTime=Wed Aug 11 07:28:45 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976151, encodeId=58e49e61514c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Wed Jun 23 10:58:31 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973812, encodeId=c10a9e381278, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b675520743, createdName=ms7000002130458668, createdTime=Tue Jun 15 18:17:41 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973186, encodeId=214a9e3186e3, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6875519986, createdName=ms2000000998113974, createdTime=Sun Jun 13 00:20:21 CST 2021, time=2021-06-13, status=1, ipAttribution=)]
    2021-06-23 LL求知的小罗罗

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1007569, encodeId=7267100e56952, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/af48f958601f48bd84e482cc4cb7adca/cbd79671c0e048498641df128b52a444.jpg, createdBy=5f561961370, createdName=刘奕奕), createdTime=Fri Aug 13 11:50:33 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006833, encodeId=6dad100683349, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbe82292593, createdName=121ec61em85暂无昵称, createdTime=Wed Aug 11 07:28:45 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976151, encodeId=58e49e61514c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Wed Jun 23 10:58:31 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973812, encodeId=c10a9e381278, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b675520743, createdName=ms7000002130458668, createdTime=Tue Jun 15 18:17:41 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973186, encodeId=214a9e3186e3, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6875519986, createdName=ms2000000998113974, createdTime=Sun Jun 13 00:20:21 CST 2021, time=2021-06-13, status=1, ipAttribution=)]
    2021-06-15 ms7000002130458668

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1007569, encodeId=7267100e56952, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/af48f958601f48bd84e482cc4cb7adca/cbd79671c0e048498641df128b52a444.jpg, createdBy=5f561961370, createdName=刘奕奕), createdTime=Fri Aug 13 11:50:33 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006833, encodeId=6dad100683349, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbe82292593, createdName=121ec61em85暂无昵称, createdTime=Wed Aug 11 07:28:45 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976151, encodeId=58e49e61514c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/49965d9363c8465cbebfe436532e8aaa/1ad60eb0fe5a4201a49971544350f958.jpg, createdBy=333b5531849, createdName=LL求知的小罗罗, createdTime=Wed Jun 23 10:58:31 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973812, encodeId=c10a9e381278, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b675520743, createdName=ms7000002130458668, createdTime=Tue Jun 15 18:17:41 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973186, encodeId=214a9e3186e3, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6875519986, createdName=ms2000000998113974, createdTime=Sun Jun 13 00:20:21 CST 2021, time=2021-06-13, status=1, ipAttribution=)]
    2021-06-13 ms2000000998113974

    值得学习

    0

拓展阅读

2014年加拿大炎症性肠病(IBD)与静脉血栓防治共识意见:加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准(修订版)

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明:应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE指南:内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践指南:应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25